Inhibition of nonalcoholic fatty liver disease in mice by selective inhibition of mTORC1

被引:87
作者
Gosis, Bridget S. [1 ]
Wada, Shogo [1 ]
Thorsheim, Chelsea [1 ]
Li, Kristina [1 ]
Jung, Sunhee [2 ]
Rhoades, Joshua H. [1 ,3 ,4 ]
Yang, Yifan [1 ]
Brandimarto, Jeffrey [1 ]
Li, Li [1 ]
Uehara, Kahealani [5 ,6 ]
Jang, Cholsoon [2 ]
Lanza, Matthew [7 ]
Sanford, Nathan B. [1 ]
Bornstein, Marc R. [1 ]
Jeong, Sunhye [1 ]
Titchenell, Paul M. [5 ,6 ]
Biddinger, Sudha B. [8 ]
Arany, Zoltan [1 ]
机构
[1] Univ Penn, Perelman Sch Med, Cardiovasc Inst, Philadelphia, PA 19104 USA
[2] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA
[3] Univ Penn, Perelman Sch Med, Inst Biomed Informat, Philadelphia, PA 19104 USA
[4] Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA
[5] Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA
[6] Univ Penn, Perelman Sch Med, Dept Physiol, Philadelphia, PA 19104 USA
[7] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA
[8] Harvard Med Sch, Boston Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA
关键词
HOGG-DUBE SYNDROME; TUMOR-SUPPRESSOR; MOUSE MODEL; TRANSCRIPTION FACTORS; MAMMALIAN TARGET; READ ALIGNMENT; X-RECEPTOR; COMPLEX; FIBROSIS; AKT;
D O I
10.1126/science.abf8271
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) remain without effective therapies. The mechanistic target of rapamycin complex 1 (mTORC1) pathway is a potential therapeutic target, but conflicting interpretations have been proposed for how mTORC1 controls lipid homeostasis. We show that selective inhibition of mTORC1 signaling in mice, through deletion of the RagC/D guanosine triphosphatase-activating protein folliculin (FLCN), promotes activation of transcription factor E3 (TFE3) in the liver without affecting other mTORC1 targets and protects against NAFLD and NASH. Disease protection is mediated by TFE3, which both induces lipid consumption and suppresses anabolic lipogenesis. TFE3 inhibits lipogenesis by suppressing proteolytic processing and activation of sterol regulatory element-binding protein-1c (SREBP-1c) and by interacting with SREBP-1c on chromatin. Our data reconcile previously conflicting studies and identify selective inhibition of mTORC1 as a potential approach to treat NASH and NAFLD.
引用
收藏
页码:264 / +
页数:63
相关论文
共 89 条
[1]   Lysosomal metabolomics reveals V-ATPase- and mTOR-dependent regulation of amino acid efflux from lysosomes [J].
Abu-Remaileh, Monther ;
Wyant, Gregory A. ;
Kim, Choah ;
Laqtom, Nouf N. ;
Abbasi, Maria ;
Chan, Sze Ham ;
Freinkman, Elizaveta ;
Sabatini, David M. .
SCIENCE, 2017, 358 (6364) :807-+
[2]  
Anderson EL, 2008, P NATL ACAD SCI USA, V105, P14976, DOI [10.1073/pnas.0807297105, 10.1038/s41598-019-45839-z]
[3]   Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease [J].
Angulo, Paul ;
Kleiner, David E. ;
Dam-Larsen, Sanne ;
Adams, Leon A. ;
Bjornsson, Einar S. ;
Charatcharoenwitthaya, Phunchai ;
Mills, Peter R. ;
Keach, Jill C. ;
Lafferty, Heather D. ;
Stahler, Alisha ;
Haflidadottir, Svanhildur ;
Bendtsen, Flemming .
GASTROENTEROLOGY, 2015, 149 (02) :389-+
[4]   Kidney-targeted Birt-Hogg-Dube gene inactivation in a mouse model: Erk1/2 and Akt-mTOR activation, cell hyperproliferation, and polycystic kidneys [J].
Baba, Masaya ;
Furihata, Mutsuo ;
Hong, Seung-Beom ;
Tessarollo, Lino ;
Haines, Diana C. ;
Southon, Eileen ;
Patel, Vishal ;
Igarashi, Peter ;
Alvord, W. Gregory ;
Leighty, Robert ;
Yao, Masahiro ;
Bernardo, Marcelino ;
Ileva, Lilia ;
Choyke, Peter ;
Warren, Michelle B. ;
Zbar, Berton ;
Linehan, W. Marston ;
Schmidt, Laura S. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (02) :140-154
[5]   Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling [J].
Baba, Masaya ;
Hong, Seung-Beom ;
Sharma, Nirmala ;
Warren, Michelle B. ;
Nickerson, Michael L. ;
Iwamatsu, Akihiro ;
Esposito, Dominic ;
Gillette, William K. ;
Hopkins, Ralph F., III ;
Hartley, James L. ;
Furihata, Mutsuo ;
Oishi, Shinya ;
Zhen, Wei ;
Burke, Terrence R., Jr. ;
Linehan, W. Marston ;
Schmidt, Laura S. ;
Zbar, Berton .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (42) :15552-15557
[6]   Lipid Delivery Systems for Nucleic-Acid-Based-Drugs: From Production to Clinical Applications [J].
Barba, Anna Angela ;
Bochicchio, Sabrina ;
Dalmoro, Annalisa ;
Lamberti, Gaetano .
PHARMACEUTICS, 2019, 11 (08)
[7]   Exit from Pluripotency Is Gated by Intracellular Redistribution of the bHLH Transcription Factor Tfe3 [J].
Betschinger, Joerg ;
Nichols, Jennifer ;
Dietmann, Sabine ;
Corrin, Philip D. ;
Paddison, Patrick J. ;
Smith, Austin .
CELL, 2013, 153 (02) :335-347
[8]   Dyrk1b promotes hepatic lipogenesis by bypassing canonical insulin signaling and directly activating mTORC2 in mice [J].
Bhat, Neha ;
Narayanan, Anand ;
Fathzadeh, Mohsen ;
Kahn, Mario ;
Zhang, Dongyan ;
Goedeke, Leigh ;
Neogi, Arpita ;
Cardone, Rebecca L. ;
Kibbey, Richard G. ;
Fernandez-Hernando, Carlos ;
Ginsberg, Henry N. ;
Jain, Dhanpat ;
Shulman, Gerald, I ;
Mani, Arya .
JOURNAL OF CLINICAL INVESTIGATION, 2022, 132 (03)
[9]   Gene editing in the context of an increasingly complex genome [J].
Blighe, K. ;
DeDionisio, L. ;
Christie, K. A. ;
Chawes, B. ;
Shareef, S. ;
Kakouli-Duarte, T. ;
Chao-Shern, C. ;
Harding, V. ;
Kelly, R. S. ;
Castellano, L. ;
Stebbing, J. ;
Lasky-Su, J. A. ;
Nesbit, M. A. ;
Moore, C. B. T. .
BMC GENOMICS, 2018, 19
[10]   Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source [J].
Boland, Michelle L. ;
Oro, Denise ;
Tolbol, Kirstine S. ;
Thrane, Sebastian T. ;
Nielsen, Jens Christian ;
Cohen, Taylor S. ;
Tabor, David E. ;
Fernandes, Fiona ;
Tovchigrechko, Andrey ;
Veidal, Sanne S. ;
Warrener, Paul ;
Sellman, Bret R. ;
Jelsing, Jacob ;
Feigh, Michael ;
Vrang, Niels ;
Trevaskis, James L. ;
Hansen, Henrik H. .
WORLD JOURNAL OF GASTROENTEROLOGY, 2019, 25 (33) :4904-4920